| O |
|
Objective Assessment of Pulmonary Embolism Can Be Deferred without Risk
|
| Siragusa S, Malato A, Giarratano A, Falaschi F, Porro F, Bonifacio G, Anastasio R, Mariani G |
| |
|
Observation of in vivo Proplatelet formation During Thrombopoiesis. Apoptosis is Not involved in the Process of Proplatelet formation
|
| Kozuma Y, Kojima H, Kawamoto T, Nagasawa T |
| |
|
Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials
|
| Anderson Jr FA, Decousus H, FitzGerald G, Bergmann JF, Froehlich JB, Nakamura M, Spyropoulos AC, Zotz RB, Spencer F, Turpie AGG |
| |
|
Obstetric Experience of Carriers of Haemophilia
|
| Khan A, Lee CA, Shiltagh N, Pollard D, Kadir R |
| |
|
Occult Bleeding During Long-term Treatment with Aspirin, Warfarin, or Both after Myocardial Infarction. A WARIS-II Subgroup Analysis
|
| Hurlen M, Seljeflot I, Eikvar L, Arnesen H |
| |
|
Occupancy-Dependent Interaction Between Platelet Integrin aIIbb3 and ICln
|
| Larkin D, Moran N |
| |
|
Occurrence of Venous Thrombosis (VT) Is Not Increased in Women Taking Postmenopausal Hormonal Replacement Therapy (HRT) in the Danish Osteoporosis Prevention Study (DOPS)
|
| Kristensen SR, Abrahamsen B, Skov Madsen J, Gram J, Rejnmark L, Rud B, Jespersen J |
| |
|
O-GlcNAc Cycling Is Important for Regulated Platelet Exocytosis
|
| Crawford GL, Barber HK, Hart GW, Whiteheart SW |
| |
|
Optimal Oral Anticoagulation Therapy and Major Bleeding in Patients with Heart Diseases in a Peruvian Heart Institute
|
| Cotrina R, Villar A |
| |
|
Optimisation of Ristocetin Cofactor Test for Low Activity Samples
|
| Cortina V, Grancha S, Haya S, Pascual S, Cid A, Casaña P, Aznar JA |
| |
|
Optimising Anticoagulant Management Strategies through the Use of Validated Educational Interventions
|
| Newall F, Johnston L, Monagle P |
| |
|
Optimizing Thromboembolic and Stroke Prevention: Interim Analysis of a Randomized Controlled Trial of Pharmacist-Managed Oral Anticoagulotherapy (PHARMA Trial)
|
| Blais N, Lalonde L, Brassard J, Fournier M, Martineau J, Blais L, Perreault S, Vanier M-C |
| |
|
Oral Anticoagulant Treatment (OAT) with Portable PT Monitor in Primary Health Care Centres with Immediate Dose Adjustment by the Hospital OAT Unit
|
| López-Fernández MF, Noya MS, Martínez-Bugallo A, Vázquez-González G, Carnero J, González-Enríquez E, Batlle J |
| |
|
Oral Anticoagulation in Children. Have We Made Any Progress?
|
| Bonduel M |
| |
|
Oral Anticoagulation in Patients over 80 Years with Atrial Fibrillation
|
| Casais P, Meschengieser SS, Sanchez-Luceros A, Lazzari MA |
| |
|
Oral Anticoagulation Laboratory Control: Comparison between Two Differents Methods
|
| De Piano LPA, Rached RA, Cavalheiro-Filho C, Strunz CMC, Chamone DAF, Ramires JAF |
| |
|
Oral But Not Subcutaneous Heparin Prevents Heparanase mRNA Upregulation in Liver and Kidney of High Glucose Treated Rats
|
| Woytowich AE, Wice SM, Hiebert LM |
| |
|
Oral Contraceptives in the Management of Rare Coagulation Bleeding Disorders
|
| Girolami A, Spiezia L, Sartori MT, Morello M, Zanon E |
| |
|
Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis
|
| Myers D, Wrobleski S, Crandall D, Farris D, Elokdah H, Mayer S, Henke P, Schaub R, Wakefield T |
| |
|
Oral Surgery in Patients on Oral Anticoagulant Therapy: A Randomized Comparison of Different INR Targets
|
| Sacco R, Sacco M, Trentini S, Carpenedo M, Moia M |
| |
|
Orientia Tsutsugamushi Infection (scrub typhus) Is Associated with an Infraclinical Activation of the Coagulation System But Not with an Activation of Endothelial Cells
|
| Toulon PA, Farrugia C, Cuzon G, Burnouf T, Watt G |
| |
|
Orthopedic Outcome in Patients With Severe Hemophilia Under Prophylactic Treatment–Benefit of an Early Long-term Prophylaxis?
|
| Meister S, Christensen K, Weidenhammer A, Spranger T, Auerswald G |
| |
|
Otamixaban, a Direct Factor Xa Inhibitor, More Potently Inhibits Experimental Coronary Thrombosis than Bivalirudin, a Direct Thrombin Inhibitor
|
| Just M, Lorenz M, Skrzipczyk HJ, Hinder M, Laux V |
| |
|
Our Experiences with the Determination of ProC Global Test and with the Interpretation of Results
|
| Slezáková E, Pecka M, Dytrychová V, Nekolová J |
| |
|
Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials
|
| Davidson BL, Buller HR, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AEM, Cariou R, Lensing AWA |
| |
|
Outreach Anticoagulation Project For Injecting Drug Users With Deep Vein Thrombosis: A Randomised Controlled Trial
|
| Dawson DJ, Shiach CR, Mackway-Jones K, Peters L |
| |
|
Over Estimation of Aspirin Resistance: 1 Out of 143 Patients Exhibiting True Aspirin Resistance
|
| Tantry U, Bliden KP, Yoho J, Hayes K, Kreutz Y, Gurbel PA |
| |
|
Oxidant Signaling as a Mediator of Platelet Procoagulant Activity and Coated Platelet Formation
|
| Jobe SM, Lentz SR, Di Paola J |
| |
|
Oxidative Modification of Low-density Lipoprotein (LDL) and OxLDL/b2GPI Complexes in Patients with Infectious Endocarditis: Possible Role in Aortic Valve Disease
|
| Lopez LR, Hurley BL, Durante-Mangoni E, Simpson DF, Tripodi MF, Guardascione M, Matsuura E, Ames PRJ |
| |
|
Oxidized Fibrinogen Affects Blood Rheology (in vitro Study)
|
| Roitman E, Dementieva I, Azizova O, Morozov Yu, Aseychev A |
| |
